BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls
- PMID: 16554070
- DOI: 10.1016/j.jpsychires.2006.01.014
BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls
Abstract
Alzheimer's disease (AD) and normal pressure hydrocephalus (NPH) are common forms of dementia in the elderly. Recent findings have suggested an involvement of brain-derived neurotrophic factor (BDNF) in the pathogenesis of AD. BDNF is an endogenous protein involved in the maintenance of neuronal function, synaptic plasticity and structural integrity in the adult brain. BDNF serum and cerebrospinal fluid (CSF) concentrations were assessed by a sensitive ELISA in 27 AD patients in comparison to 9 NPH patients and 28 age-matched healthy controls (10 CSF samples). We found a significant decrease of BDNF serum concentration in AD (18.6ng/ml) and NPH patients (18.1ng/ml) as compared to healthy controls (21.3ng/ml; p=0.041/p=0.017). BDNF serum concentrations did not correlate with CSF levels, age or MMSE scores both in AD and NPH patients. In unconcentrated CSF samples, BDNF could be detected in AD patients in 8/27 cases (29.6%; mean of 4.6pg/ml), in NPH patients in 1/9 cases (11.1%; mean of 6.4pg/ml) and in the control subjects in 5/10 cases (50%; mean of 1.6pg/ml) with no significant differences as regards mean concentration and frequency of detectable BDNF in CSF. The decrease of BDNF serum levels in AD and NPH may reflect a lack of trophic support and thus contribute to progressive degeneration in both diseases. In contrast to serum, CSF seems to be no useful source to determine BDNF in AD or NPH because of too low concentrations. Further examinations have to follow to elucidate the potential sources and the meaning of reduced BDNF levels in the blood in AD and NPH.
Similar articles
-
Stage-dependent BDNF serum concentrations in Alzheimer's disease.J Neural Transm (Vienna). 2006 Sep;113(9):1217-24. doi: 10.1007/s00702-005-0397-y. Epub 2005 Dec 16. J Neural Transm (Vienna). 2006. PMID: 16362629
-
Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.Ann Neurol. 1992 Dec;32(6):733-42. doi: 10.1002/ana.410320606. Ann Neurol. 1992. PMID: 1471863
-
Tau protein is a potential biological marker for normal pressure hydrocephalus.Psychiatry Clin Neurosci. 2000 Apr;54(2):199-202. doi: 10.1046/j.1440-1819.2000.00658.x. Psychiatry Clin Neurosci. 2000. PMID: 10803815
-
The differential diagnosis of Alzheimer's disease. Cerebral atrophy versus normal pressure hydrocephalus.Neuroimaging Clin N Am. 1995 Feb;5(1):19-31. Neuroimaging Clin N Am. 1995. PMID: 7743082 Review.
-
Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis.Lancet Neurol. 2003 Aug;2(8):506-11. doi: 10.1016/s1474-4422(03)00487-3. Lancet Neurol. 2003. PMID: 12878439 Review.
Cited by
-
Implementing neuronal plasticity in NeuroAIDS: the experience of brain-derived neurotrophic factor and other neurotrophic factors.J Neuroimmune Pharmacol. 2014 Mar;9(2):80-91. doi: 10.1007/s11481-013-9488-y. Epub 2013 Jul 6. J Neuroimmune Pharmacol. 2014. PMID: 23832285 Free PMC article. Review.
-
Association of Cigarette Smoking With Cerebrospinal Fluid Biomarkers of Neurodegeneration, Neuroinflammation, and Oxidation.JAMA Netw Open. 2020 Oct 1;3(10):e2018777. doi: 10.1001/jamanetworkopen.2020.18777. JAMA Netw Open. 2020. PMID: 33006621 Free PMC article.
-
Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory.Cogn Affect Behav Neurosci. 2015 Sep;15(3):625-43. doi: 10.3758/s13415-015-0343-x. Cogn Affect Behav Neurosci. 2015. PMID: 25784293 Free PMC article.
-
Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.Int J Mol Sci. 2019 Jan 10;20(2):257. doi: 10.3390/ijms20020257. Int J Mol Sci. 2019. PMID: 30634650 Free PMC article.
-
Brain-derived neurotrophic factor in neurodegenerative diseases.Nat Rev Neurol. 2009 Jun;5(6):311-22. doi: 10.1038/nrneurol.2009.54. Nat Rev Neurol. 2009. PMID: 19498435 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical